Microsoft Corporation (MSFT) Stock Forecast
Data as of Jul 31, 2026Technology · Current price $462.84 (+2.58%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 15, 2026 | William Power | Robert W. Baird | $500.00 | +8.0% |
| Apr 14, 2026 | Billy Fitzsimmons | Piper Sandler | $500.00 | +8.0% |
| Apr 10, 2026 | Stefan Slowinski | BNP Paribas | $556.00 | +20.1% |
| Jan 29, 2026 | Thomas Blakey | Cantor Fitzgerald | $590.00 | +27.5% |
| Jan 29, 2026 | Brad Zelnick | Deutsche Bank | $575.00 | +24.2% |
| Jan 29, 2026 | Brad Reback | Stifel Nicolaus | $540.00 | +16.7% |
| Jan 29, 2026 | Keith Bachman | BMO Capital | $575.00 | +24.2% |
| Jan 29, 2026 | Patrick Colville | Scotiabank | $600.00 | +29.6% |
| Jan 29, 2026 | Brent Bracelin | Piper Sandler | $600.00 | +29.6% |
| Jan 29, 2026 | Mark Moerdler | Bernstein | $641.00 | +38.5% |
| Jan 29, 2026 | Jackson Ader | KeyBanc | $600.00 | +29.6% |
| Jan 29, 2026 | William Power | Robert W. Baird | $540.00 | +16.7% |
| Jan 29, 2026 | Raimo Lenschow | Barclays | $600.00 | +29.6% |
| Jan 26, 2026 | Brad Reback | Stifel Nicolaus | $520.00 | +12.3% |
| Jan 21, 2026 | Alex Haissl | Redburn Partners | $450.00 | -2.8% |
| Nov 19, 2025 | John DiFucci | Guggenheim | $675.00 | +45.8% |
| Oct 30, 2025 | Thomas Blakey | Cantor Fitzgerald | $639.00 | +38.1% |
| Oct 30, 2025 | Gil Luria | D.A. Davidson | $650.00 | +40.4% |
| Oct 30, 2025 | Hannah Rudoff | Piper Sandler | $650.00 | +40.4% |
| Oct 30, 2025 | Brad Reback | Stifel Nicolaus | $640.00 | +38.3% |
Top Analysts Covering MSFT
MSFT vs Sector & Market
| Metric | MSFT | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.07 | 2.36 | 2.42 |
| Analyst Count | 58 | 14 | 19 |
| Target Upside | +43.4% | +1710.8% | +18.0% |
| P/E Ratio | 27.55 | 37.65 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $86.61B | $89.13B | $90.82B | 12 |
| 2026-12-31 | $90.93B | $93.58B | $95.35B | 12 |
| 2027-03-31 | $91.65B | $94.32B | $96.11B | 12 |
| 2027-06-30 | $98.83B | $101.71B | $103.64B | 12 |
| 2027-09-30 | $100.05B | $102.96B | $104.91B | 12 |
| 2027-12-31 | $104.74B | $107.79B | $109.83B | 12 |
| 2028-03-31 | $105.84B | $108.92B | $110.98B | 11 |
| 2028-06-30 | $113.76B | $117.07B | $119.29B | 11 |
| 2029-06-30 | $500.03B | $518.80B | $537.06B | 16 |
| 2030-06-30 | $620.44B | $643.73B | $666.40B | 22 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $4.41 | $4.58 | $4.69 | 9 |
| 2026-12-31 | $4.51 | $4.68 | $4.80 | 10 |
| 2027-03-31 | $4.49 | $4.66 | $4.78 | 10 |
| 2027-06-30 | $4.81 | $4.99 | $5.11 | 9 |
| 2027-09-30 | $5.08 | $5.27 | $5.40 | 9 |
| 2027-12-31 | $5.21 | $5.41 | $5.54 | 10 |
| 2028-03-31 | $5.29 | $5.50 | $5.63 | 11 |
| 2028-06-30 | $5.67 | $5.89 | $6.03 | 10 |
| 2029-06-30 | $25.33 | $26.58 | $27.80 | 16 |
| 2030-06-30 | $31.83 | $33.41 | $34.93 | 8 |
Frequently Asked Questions
What is the analyst consensus for MSFT?
The consensus among 58 analysts covering Microsoft Corporation (MSFT) is Buy with an average price target of $551.33.
What is the highest price target for MSFT?
The highest price target for MSFT is $700.00, set by Michael Turrin at Wells Fargo on 2025-10-30.
What is the lowest price target for MSFT?
The lowest price target for MSFT is $115.00, set by Brent Bracelin at Piper Sandler on 2023-01-09.
How many analysts cover MSFT?
58 analysts have issued ratings for Microsoft Corporation in the past 12 months.
Is MSFT a buy or sell right now?
Based on 58 analyst ratings, MSFT has a consensus rating of Buy (2.07/5) with a +43.4% upside to the consensus target of $551.33.
What are the earnings estimates for MSFT?
Analysts estimate MSFT will report EPS of $4.58 for the period ending 2026-09-30, with revenue estimated at $89.13B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.